Thermo Fisher Scientific Inc. Ranks 71st in Trading Volume with 10.09 Billion Shares as New Cytometer Boosts Research Efficiency

On May 29, 2025, Thermo Fisher Scientific Inc. (TMO) saw a trading volume of 10.09 billion, ranking 71st in the day's stock market activity. The company's stock price increased by 0.40%.

Thermo Fisher Scientific Inc. has launched the spectral-enabled Invitrogen™ Attune™ Xenith™ Flow Cytometer, a new tool designed to enhance the efficiency and accuracy of cellular research. This innovative cytometer leverages Thermo Fisher’s core acoustic focusing technology, providing researchers with faster results and more detailed insights from cellular samples. The device is equipped with six lasers and 51 fluorescent detectors, enabling high-speed analysis and reducing sample waste through its clog-resistant design. This advancement is part of Thermo Fisher's ongoing commitment to providing cutting-edge solutions that improve lab productivity and research capabilities.

The new cytometer addresses common issues faced by traditional cytometers, such as complex data analysis and frequent clogs, by offering user-friendly software and innovative features. These include high-speed acoustic technology, a clog-resistant design, and the ability to perform both spectral unmixing and conventional flow cytometry. The device is designed for extended operation without needing fluid changes, ensuring ease of use for researchers of all experience levels. The Attune Xenith Flow Cytometer is the latest addition to Thermo Fisher's extensive portfolio of flow cytometry solutions, reinforcing the company's dedication to advancing scientific knowledge through innovative tools.